Deutsche Bank Ag\ Xencor Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Xencor Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 37,913 shares of XNCR stock, worth $783,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,913

Previous 29,753 27.43%

Holding current value

$783,661

Previous $563,000 35.35%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.7 - $21.65 $128,112 - $176,664	8,160 Added 27.43%	37,913 $762,000
Q2 2024 Aug 14, 2024	SELL	$18.21 - $24.5 $22,507 - $30,282	-1,236 Reduced 3.99%	29,753 $563,000
Q1 2024 May 15, 2024	SELL	$18.65 - $26.52 $28,161 - $40,045	-1,510 Reduced 4.65%	30,989 $685,000
Q4 2023 Feb 14, 2024	SELL	$16.53 - $21.42 $9,901 - $12,830	-599 Reduced 1.81%	32,499 $689,000
Q3 2023 Nov 09, 2023	BUY	$20.08 - $25.39 $76,404 - $96,608	3,805 Added 12.99%	33,098 $666,000
Q2 2023 Aug 14, 2023	SELL	$24.77 - $29.9 $272,965 - $329,498	-11,020 Reduced 27.34%	29,293 $731,000
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $176,148 - $250,816	6,788 Added 20.25%	40,313 $1.12 Million
Q4 2022 Feb 13, 2023	BUY	$24.79 - $30.86 $209,624 - $260,952	8,456 Added 33.73%	33,525 $872,000
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $159,783 - $210,535	-6,490 Reduced 20.56%	25,069 $651,000
Q2 2022 Aug 11, 2022	SELL	$19.74 - $29.01 $94,278 - $138,551	-4,776 Reduced 13.14%	31,559 $863,000
Q1 2022 May 13, 2022	SELL	$26.68 - $41.63 $93,646 - $146,121	-3,510 Reduced 8.81%	36,335 $970,000
Q4 2021 Feb 11, 2022	BUY	$33.67 - $43.44 $39,023 - $50,346	1,159 Added 3.0%	39,845 $1.6 Million
Q3 2021 Nov 04, 2021	SELL	$30.65 - $35.68 $31,661 - $36,857	-1,033 Reduced 2.6%	38,686 $1.26 Million
Q2 2021 Aug 11, 2021	SELL	$34.33 - $44.68 $48,096 - $62,596	-1,401 Reduced 3.41%	39,719 $1.37 Million
Q1 2021 May 13, 2021	SELL	$40.81 - $53.88 $126,633 - $167,189	-3,103 Reduced 7.02%	41,120 $1.77 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $359,047 - $466,869	9,802 Added 28.48%	44,223 $1.93 Million
Q3 2020 Nov 12, 2020	BUY	$30.09 - $43.02 $68,514 - $97,956	2,277 Added 7.08%	34,421 $1.34 Million
Q2 2020 Aug 13, 2020	SELL	$27.76 - $33.42 $647,613 - $779,655	-23,329 Reduced 42.05%	32,144 $1.04 Million
Q1 2020 May 14, 2020	SELL	$20.69 - $37.79 $494,573 - $903,332	-23,904 Reduced 30.11%	55,473 $1.66 Million
Q4 2019 Feb 14, 2020	BUY	$32.75 - $41.43 $2.15 Million - $2.72 Million	65,540 Added 473.66%	79,377 $2.73 Million
Q3 2019 Nov 14, 2019	SELL	$33.73 - $46.27 $442,301 - $606,738	-13,113 Reduced 48.66%	13,837 $466,000
Q2 2019 Aug 14, 2019	SELL	$29.6 - $40.93 $689,058 - $952,809	-23,279 Reduced 46.35%	26,950 $1.1 Million
Q1 2019 May 15, 2019	BUY	$27.85 - $38.09 $391,431 - $535,354	14,055 Added 38.85%	50,229 $1.56 Million
Q4 2018 Feb 14, 2019	SELL	$32.39 - $42.05 $3.32 Million - $4.31 Million	-102,566 Reduced 73.93%	36,174 $1.31 Million
Q3 2018 Dec 21, 2021	BUY	$35.69 - $47.65 $1.64 Million - $2.19 Million	45,927 Added 49.48%	138,740 $5.41 Million
Q3 2018 Nov 14, 2018	SELL	$35.69 - $47.65 $488,703 - $652,471	-13,693 Reduced 12.86%	92,813 $3.62 Million
Q2 2018 Apr 21, 2020	BUY	$28.41 - $42.41 $693,232 - $1.03 Million	24,401 Added 29.72%	106,506 $3.94 Million
Q2 2018 Aug 14, 2018	BUY	$28.41 - $42.41 $884,232 - $1.32 Million	31,124 Added 61.05%	82,105 $3.04 Million
Q1 2018 Oct 18, 2019	BUY	$21.18 - $33.78 $205,128 - $327,159	9,685 Added 23.45%	50,981 $1.53 Million
Q1 2018 May 15, 2018	SELL	$21.18 - $33.78 $2.42 Million - $3.85 Million	-114,047 Reduced 73.42%	41,296 $1.24 Million
Q4 2017 Feb 14, 2018	BUY	$19.29 - $24.83 $1.29 Million - $1.66 Million	66,656 Added 75.16%	155,343 $3.4 Million
Q3 2017 Nov 14, 2017	BUY	$19.61 - $23.35 $1.74 Million - $2.07 Million	88,687	88,687 $2.03 Million

Others Institutions Holding XNCR

# of Institutions

216

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.23B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account